简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-08-19 18:09 Veristat is Recognized on the 2022 Inc. 5000 List of America’s Fastest-Growing Private Companies
2022-08-19 15:44 Exscientia Business Update for Second Quarter and First Half 2022
2022-08-19 13:32 Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022
2022-08-18 13:26 Tavneos® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA)
2022-08-16 17:38 lear Files Amended Answer to the Government’s Lawsuit on COVID-19 Statements; Provides Still More Data In Support of Xlear’s Use as Additional Layer of Protection
2022-08-12 10:36 Zayed Sustainability Prize 2023 Demonstrates Global Reach and Impact with over 4,500 Submissions
2022-08-11 18:45 Exscientia to Report Second Quarter 2022 Financial Results on August 17, 2022
2022-08-11 16:26 Nonprofit Funding Platform Heroe5 Launches The Good Society, Embracing Web3 Approach to the Sustainable Financial Benefit for Charities
2022-08-10 17:37 Ferring Announces U.S. FDA Advisory Committee Meeting for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic
2022-08-08 09:29 Ai Fukuhara Became a Spokesperson of Japanese Electric Bed for Elderly Brand PLATZ
2022-08-05 14:36 GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution
2022-08-04 13:16 SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
2022-08-04 09:34 ImmunAbs Inc. Announces US FDA Approval for a Phase 1 Clinical Trial
2022-08-03 19:16 First half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline
2022-08-03 15:24 Adalvo Acquires Its First Branded Product, Onsolis®
2022-08-02 13:12 Finalization of Vifor Pharma acquisition
2022-08-02 12:06 Graminex®, L.L.C. Completes Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence with Positive Results.
2022-08-02 10:48 Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi
2022-08-01 14:43 Takeda Delivers Strong First Quarter FY2022 Results; On Track Towards Full-Year Management Guidance
2022-07-29 16:45 Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate

Business Wire Weibo

Press Releases

Latest Releases